What Investors Actually Think When They Hear Your Valuation Number

27 July 2026

What Investors Actually Think When They Hear Your Valuation Number

Most founders walk into their first serious investor conversation believing that valuation is the negotiation. Aim high, hold your nerve, and whatever number you land on is the scoreboard for how well you did. It is an understandable belief. It is also not how the person across the table is thinking at all.

An investor hearing your number is not really asking “is this a good deal.” They are asking something closer to: how much risk have you just asked me to price, and does the number you have chosen tell me anything about your judgement. At pre-seed, there is usually no revenue, no trading history, and no comparable business to check your maths against. Your valuation is not a measurement of what your company is worth. It is a proxy, built from how much you need, how much of the company you are prepared to sell for it, and how the investor reads your confidence in both.

That distinction changes what you should actually be optimising for when you set a number, and it explains why founders who chase the highest possible valuation often end up worse off than founders who accept a lower one attached to cleaner terms. This piece works through what is really going on when you say your number out loud, and what that means for how you should arrive at it.

Why your number is a proxy, not a verdict

When there is no revenue and no track record, a valuation cannot be calculated the way a mature business’s might be. It is instead a negotiated shorthand, and one of the most common ways founders damage that negotiation before it starts is by mishandling the arithmetic itself. Confusing pre-money and post-money valuation is, by a wide margin, the most frequent numerical error at this stage. If an investor puts in £2m at a £10m pre-money valuation, they own £2m divided by £12m post-money, which is 16.7 per cent, not 20 per cent. Founders who quietly get this wrong either misprice their own company or, worse, look like they do not understand their own cap table in front of the person deciding whether to back them.

The proxy framing matters because it reorients the conversation. You are not being appraised. You are proposing a number that implies a story about growth, risk and the size of the round you need, and the investor is testing whether that story holds together, not simply whether the digit is big or small.

The UK figure nobody can quite agree on

If you go looking for “the average UK pre-seed valuation,” you will find a genuinely unhelpful spread of answers. PitchBook data, reported via UKTech News in November 2024, put average UK pre-seed pre-money valuations at £3.2m in Q3 2024, up 31 per cent year on year, with median UK seed pre-money valuation at £4m over the same period. Separately, aggregated data cited by Undo Capital put the average UK seed round size at £2.41m in 2024, against a median deal size of just £0.56m. That gap between a £2.41m average and a £0.56m median is not a contradiction so much as a signal: a small number of large raises are pulling the average well above what a typical round actually looks like.

Older, secondhand figures circulating in founder blogs still cite Beauhurst’s average pre-seed valuation at closer to £1.4m, a figure whose original context is now several years old. None of these numbers are wrong exactly. They are measuring different samples, different periods, and, more often than commentators admit, means rather than medians. Treat any single “average valuation” quoted without a named primary source and a date as a starting point for scepticism, not a benchmark to anchor your own raise against.

One further wrinkle: British Business Bank data shows UK venture-growth stage valuations actually sit below the European average, at roughly £16.8m against a £20.8m European figure in Q3 2024, which cuts against the common assumption that London commands a valuation premium simply by virtue of ecosystem maturity.

A high valuation is a floor before it is a ceiling

The instinct to chase the biggest number treats valuation as a one-off win. In practice, every subsequent round is priced relative to the last one, which means an inflated number today sets the bar your company must clear tomorrow. If growth does not keep pace, you are looking at a flat round or a down round, both of which are read by the market as a warning sign regardless of the underlying reason.

This is not only a UK phenomenon, and the clearest data on it is global rather than domestic. PitchBook figures show the down-round rate across global venture deals rose from 7 per cent in 2022 to 14 per cent in 2023, with flat rounds climbing from roughly 4 per cent to 10 per cent over the same period; Carta’s US data recorded a similar pattern, with down rounds jumping from 5.2 per cent of new fundings in Q1 2022 to 18.5 per cent by Q3 2023. No equivalent UK-only figure was available at the time of writing, which is itself worth knowing: founders quoting a precise UK down-round percentage are almost certainly extrapolating from US or global data.

There is a related, quieter risk known in venture circles as signalling risk, a concept originating with US investors Chris Dixon and Steve Anderson. If a well-known investor backs you at seed but does not follow on at the next round, other investors may read that absence as an implicit red flag, whatever the actual reason for their non-participation. A valuation set too aggressively at pre-seed makes this scenario more, not less, likely, because it narrows the pool of investors willing or able to lead the follow-on round at a higher number still.

The terms are doing more work than the number

Perhaps the least understood part of valuation is that the headline figure can matter less than the structure wrapped around it. HSBC Innovation Banking’s Venture Capital Term Sheet Guide 2025, drawn from 588 anonymised UK term sheets across 27 law firms, is one of the more substantial primary datasets on how UK deals are actually structured. It found non-participating preference shares, generally the more founder-friendly structure, appeared in 95 per cent of AI-sector term sheets in 2024 versus 88 per cent of non-AI tech deals, a concrete illustration that “hot sector” founders often win better terms, not just higher numbers.

Ashley Abrahams, Head of Origination at Guinness Ventures, has made the point directly: valuation and preference structure need to be read together, because a high valuation paired with an aggressive liquidation preference, such as a participating structure or a multiple ratchet, can leave founders worse off at exit than a lower valuation with clean terms. Glen Waters of HSBC Innovation Banking adds a related caution worth sitting with: investors sometimes describe their preferred terms as “market standard” when in reality terms vary considerably by sector, stage and prevailing conditions. The term sheet is where the real negotiation happens, and founders who fixate on the pre-money figure while nodding through the preference structure are frequently negotiating the wrong line item.

Why SEIS and EIS change the risk an investor is actually pricing

UK valuation dynamics cannot be read the same way as US ones, largely because of tax-advantaged investment schemes with no American equivalent. The SEIS scheme, as amended from April 2023, gives investors 50 per cent income tax relief on investments into companies with gross assets below £350,000 pre-investment, fewer than 25 full-time employees, and a trading history under three years, up to a lifetime company cap of £250,000 raised. The EIS scheme offers 30 per cent income tax relief for larger, slightly older companies, though the precise current gross-assets thresholds have been reported inconsistently across sources at the time of writing, with some suggesting an increase from the long-standing £15m/£16m figures towards £30m/£35m following the Autumn Budget 2025. Given how easily founders get caught out by exactly this kind of detail, treat any specific threshold as something to confirm directly with HMRC or an adviser before relying on it in a live raise.

The practical effect is this: because SEIS and EIS materially reduce an investor’s after-tax risk, they can support a higher valuation or larger round than the “raw” underlying risk would otherwise justify, particularly at pre-seed. This is a structural feature of the UK market, not a founder negotiating tactic, and it is one reason comparing “typical UK valuations” against US figures without adjusting for it is not really a like-for-like comparison.

It also affects which fundraising instrument you should use. A US-style SAFE is not built for English law or HMRC’s conditions, and using one unmodified can jeopardise investors’ SEIS or EIS relief entirely. Most UK advisers instead recommend the advance subscription agreement, the closer domestic equivalent, which HMRC requires to be non-refundable, interest-free, non-variable, and subject to a long-stop conversion date of no more than six months from signing if SEIS or EIS eligibility is to be preserved. A convertible loan note is a related but distinct instrument, and the two are often confused by founders drafting their first term sheet without specialist advice.

What your cap table says before you have said a word

Investors also read your cap table as a signal of judgement, not just arithmetic. A founding team that has retained a healthy share of the company by seed stage is generally read as a sign of sound negotiation and sustainable incentives going forward; a team that has already given away most of the business can raise doubts about future motivation and negotiating position, even though reasonable investors disagree on exactly where that line sits. Dilution compounds with every priced round, every converting instrument, and every expansion of the option pool, and one mechanism catches founders out repeatedly: the option pool shuffle, where a new investor requires the pool to be created or enlarged before the round closes, which dilutes existing shareholders, mostly founders, rather than the incoming investor. The headline valuation does not move, but the effective one does.

A separate, easy-to-miss UK quirk sits alongside this. Employee share options under an EMI scheme require their own valuation, agreed directly with HMRC’s Shares and Assets Valuation team, using a concept called “unrestricted market value” that is deliberately distinct from, and usually lower than, your investment-round valuation. Founders who leave this until after a priced round has already set a high public benchmark often find employee options become far more expensive to exercise than intended. Sorting the EMI valuation early, before a funding round pushes expectations upward, is one of the more overlooked pieces of UK-specific fundraising housekeeping.

The same number is not offered to everyone

It is worth stating plainly, because the data is unambiguous: the number an investor offers is not shaped purely by company fundamentals. A House of Commons Women and Equalities Committee report found only around 2 per cent of UK equity investment went to all-female founding teams in 2024, while all-male teams received over 80 per cent. British Business Bank data, citing the Investing in Women Code, found only 13 per cent of senior UK venture capital roles are held by women, and 48 per cent of UK VC firms have no women in senior investment positions at all. This is not simply an access gap. Sources suggest that even when female-led ventures do secure funding, they can receive comparatively lower valuations and less follow-on investment, meaning the disparity shows up in how the number is set, not only in whether funding happens at all. Any founder reading investor psychology as a purely rational, fundamentals-only process is missing part of the picture.

Getting the number right before you say it out loud

None of this means valuation does not matter. It means the number is only ever half the argument, and treating it as the whole negotiation is where founders lose ground before they realise it. Before you put a figure in front of an investor, model what your ownership actually looks like two rounds from now, not just this one, and check that against realistic runway and growth assumptions rather than the biggest number a market comparable will bear. Understand whether SEIS or EIS eligibility applies to your raise, and use an instrument built for UK law and HMRC’s conditions rather than an imported template. If you are offering options, get an EMI valuation agreed before a priced round sets the benchmark, not after. And when the term sheet arrives, read the liquidation preference and any participation rights as carefully as the pre-money figure, because that is where the economics of a good or bad outcome are actually decided.

Above all, treat any “average valuation” you read, including the figures in this piece, as a starting point for a conversation with your own investors and advisers, not a target to hit. The investor on the other side of the table is not scoring you on the size of your number. They are reading what the number, the instrument, and the terms around it say about how well you understand the deal you are asking them to do. That is the real test, and it is the one worth preparing for.

This article is for general information only and does not constitute financial, investment, tax, or legal advice. The Startup Foundry is not a regulated financial adviser. You should seek independent professional advice before making any financial, investment, or legal decisions.